Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

BACKGROUND: To reduce the risk of thromboembolic complications, clinical guidelines recommend anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although warfarin has long been the primary treatment alternative, now newer alternatives such as apixaban have proven effective i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hallinen, Taru, Soini, Erkki J., Linna, Miika, Saarni, Samuli I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988956/
https://www.ncbi.nlm.nih.gov/pubmed/27588247
http://dx.doi.org/10.1186/s40064-016-3024-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988956/
https://www.ncbi.nlm.nih.gov/pubmed/27588247
http://dx.doi.org/10.1186/s40064-016-3024-5

Ejemplares similares